PPE family protein PPE18 (Mtb39A) (Mtb39A)

Mycobacterium tuberculosis protein Mtb39A, also known as PPE family protein PPE18 or Rv1196, is a 39-kDa membrane-associated protein that is a key player in the host-pathogen interaction during tuberculosis infection. It belongs to the PPE (Pro-Pro-Glu) family, which is unique to mycobacteria and critical for virulence and immune modulation [6, 7]. Mtb39A acts as a virulence factor by inhibiting the macrophage-mediated presentation of MHC class II antigens, thereby facilitating the evasion of the host's adaptive immune system [6, 8]. Despite this role, its high immunogenicity has made it a cornerstone of modern tuberculosis vaccine development. It is a major component of the M72/AS01E subunit vaccine, which has demonstrated significant protective efficacy against active pulmonary tuberculosis in Phase IIb clinical trials [10, 13]. The protein induces a potent Th1-type immune response, primarily through the stimulation of CD4+ T cells and the production of interferon-gamma [1, 19]. Additionally, Mtb39A is utilized as a diagnostic biomarker in serological assays to detect tuberculosis infection [4, 5].

Other names

Rv1196PPE1839 kDa antigenMtb39A proteinPPE family protein PPE18

The M72/AS01E vaccine, which contains the Mtb39A antigen, induces a robust Th1-type immune response characterized by the activation of CD4+ T cells and the secretion of pro-inflammatory cytokines such as interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), and interleukin-2 (IL-2) [8, 10, 19].